PMV Pharmaceuticals is a pioneering brand that focuses on the discovery and development of small molecule drugs for the treatment of cancer, specifically targeting the p53 protein. Known as the guardian of the genome, p53 plays a crucial role in preserving DNA integrity and preventing the progression of abnormal cells. However, mutations in the p53 protein can lead to the development of cancer and resistance to treatment.

PMV Pharma utilizes its extensive research experience and insights into the p53 protein to develop customized and tumor-agnostic therapeutics that selectively target mutant p53. By leveraging over four decades of research and expertise, PMV Pharma aims to restore the function of wild-type p53 and provide effective treatment options for various types of cancer. With a strong focus on drug discovery and development, PMV Pharma is dedicated to harnessing the power of p53 to revolutionize cancer treatment and provide hope for patients worldwide